Contact CFFC


Clinical Trial Alerts – March 2019

Cystic Fibrosis Foundation distributed the following clinical trial update in March. Click the trial title to get more details.

March 11, 2019

Study to evaluate inhaled molgramostim in adults 18 years and older with cystic fibrosis

Status: Enrolling

Description: This study will look at the effectiveness of the inhaled drug molgramostim, a drug intended to treat infections in the lung.

Age: 18 Years and Older

Mutation: No Mutation Requirement

Fev1% Predicted: 30% or greater

Number of Visits: 19

Length of Participation: 72 weeks link:

Comments are closed.